1. |
Sun M, Fang S, Li W, Li C, et al.Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.Cancer Biomark, 2015, 15(1):33-40.
|
2. |
Park CS, Kim SH, Jung SL, et al.Observer variability in the sonographic evaluation of thyroid nodules.J Clin Ultrasound, 2010, 38(6):287-293.
|
3. |
Li QS, Chen SH, Xiong HH, et al.Papillary thyroid carcinoma on sonography.Clin Imaging, 2010, 34(2):121-126.
|
4. |
Jun HH, Kim SM, Kim BW, et al.Overcoming the limitations of fine needle aspiration biopsy:detection of lateral neck node metastasis in papillary thyroid carcinoma.Yonsei Med J, 2015, 56(1):182-188.
|
5. |
Clark OH.Thyroid cancer and lymph node metastases.J Surg Oncol, 2011, 103(6):615-618.
|
6. |
Yadav L, Puri N, Rastogi V, et al.Matrix metalloproteinases and cancer-roles in threat and therapy.Asian Pac J Cancer Prev, 2014, 15(3):1085-1091.
|
7. |
Fink K, Boratyński J.The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis.Postepy Hig Med Dosw (Online), 2012, 66:609-628.
|
8. |
Nagase H, Visse R, Murphy G.Structure and function of matrix metalloproteinases and TIMPs.Cardiovasc Res, 2006, 69(3):562-573.
|
9. |
Gialeli C, Theocharis AD, Karamanos NK.Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.FEBS J, 2011, 278(1):16-27.
|
10. |
Guo JQ, Zheng QH, Chen H, et al.Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE-cadherin/EphA2/MMP9/MMP2 expression.Int J Oncol, 2014, 45(3):1065-1072.
|
11. |
Lovaas JD, Zhu L, Chiao CY, et al.SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.Prostate, 2013, 73(5):522-530.
|
12. |
Bae GY, Choi SJ, Lee JS, et al.Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer.Oncotarget, 2013, 4(12):2512-2522.
|
13. |
Uraoka N, Oue N, Sakamoto N, et al.NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression.Cancer Sci, 2014, 105(1):134-140.
|
14. |
Grelewski PG, Bar JK.The role of p53 protein and MMP-2 tumor/ stromal cells expression on progressive growth of ovarian neoplasms.Cancer Invest, 2013, 31(7):472-479.
|
15. |
Jacob A, Jing J, Lee J, et al.Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells.J Cell Sci, 2013, 126(Pt 20):4647-4658.
|
16. |
Maquoi E, Frankenne F, Baramova E, et al.Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines.J Biol Chem, 2000, 275(15):11368-11378.
|
17. |
Deryugina EI, Ratnikov B, Monosov E, et al.MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells.Exp Cell Res, 2001, 263(2):209-223.
|
18. |
Hess AR, Seftor EA, Seftor RE, et al.Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.Cancer Res, 2003, 63(16):4757-4762.
|
19. |
Sood AK, Fletcher MS, Coffin JE, et al.Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.Am J Obstet Gynecol, 2004, 190(4):899-909.
|
20. |
刘臻, 滕绪永, 张恒玮, 等.甲状腺乳头状癌组织中MMP-9、趋化因子受体CXCR7表达的生物学意义.现代肿瘤医学, 2014, 22(4):802-805.
|
21. |
Rahman MA, Dhar DK, Yamaguchi E, et al.Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver:possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.Clin Cancer Res, 2001, 7(5):1325-1332.
|
22. |
Saffar H, Sanii S, Emami B, et al.Evaluation of MMP2 and Caspase-3 expression in 107 cases of papillary thyroid carcinoma and its association with prognostic factors.Pathol Res Pract, 2013, 209(3):195-199.
|
23. |
Wu G, Zhou Y, Li T, et al.Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.J Int Med Res, 2013, 41(3):816-824.
|
24. |
Sato H, Takino T, Okada Y, et al.A matrix metalloproteinase expressed on the surface of invasive tumor cells.Nature, 1994, 370(1):61-65.
|
25. |
Ip YC, Cheung ST, Leung KL, et al.Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.World J Gastroenterol, 2005, 11(40):6269-6276.
|
26. |
Mimori K, Fukagawa T, Kosaka Y, et al.A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.Ann Surg Oncol, 2008, 15(10):2934-2942.
|
27. |
Perentes JY, Kirkpatrick ND, Nagano S, et al.Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors.Cancer Res, 2011, 71(13):4527-4538.
|
28. |
Yao G, He P, Chen L, et al.MT1-MMP in breast cancer:induction of VEGF-C correlates with metastasis and poor prognosis.Cancer Cell Int, 2013, 13(1):98.
|